Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

BDH Industries Ltd Stock Analysis

Small Cap
Evaluated by 370 users | BSE: 524828 | NSE: MBIND |
Pharmaceuticals & Drugs
BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 4.87%6.22%8.01%8.81%8.61%9.89%9.63%10.31%12.06%13.55%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 37.340.240.542.644.646.143.74151.759.5
Y-o-Y Gr. Rt.-7.6%1%5.2%4.6%3.4%-5.3%-6.1%26%15.1%
Adjusted EPS (Rs.) 1.441.882.9244.465.585.86.548.3910.32
Y-o-Y Gr. Rt.-30.6%55.3%37%11.5%25.1%3.9%12.8%28.3%23%
Book Value per Share (Rs.) 32.1733.3635.137.3439.0344.6348.0251.5656.9463.74
Adjusted Net Profit 0.81.11.72.32.63.23.33.84.85.9
Net Op. Cash Flow (Rs. Cr.) 5.48.653.96.24.37.2-0.2-3.611.4
Debt to Cash Flow from Ops 1.630.71.552.921.432.21.17-51.53-3.590.81
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
BDH Industries Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 5.3%5.9%10.8%15.1%
Adjusted EPS 24.5%18.3%21.2%23%
Book Value per Share 7.910.39.911.9
Share Price 23.8% 4.9% 15.5% 72.6%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 4.155.297.8810.2410.8712.5111.8112.4514.7316.37
Operating Profit Margin (%) 7.448.378.118.598.538.8511.0113.0813.5515.09
Net Profit Margin (%) 2.232.74.155.45.756.977.649.189.349.99
Debt to Equity 0.470.310.380.520.390.370.30.250.390.25
Working Capital Days 188132122127132126111132155146
Cash Conversion Cycle 1207033130-18-34-44-13-4
Entity Percentage Holding
Promoters 49.79%
Non-Institutions 50.21%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of BDH Industries Ltd's performance infers:

BDH Industries Ltd earnings have grown by 18.3%, whereas share price has appreciated 4.9% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of BDH Industries Ltd share prices over the last 10 years. Here is what we found out:

BDH Industries Ltd share price has appreciated 20% annually over the past ten years.

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.

Products offered by the Company:

Some of its therapeutical categories are:

1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables

It also manufactures sildenafil citrate tablets for male impotency

Achievements:

  • The Government of the India has accorded 'Star Export House' status to the company
  • The Government of India also accredited the company with WHO-GMP Certification since 1982.
  • It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
  • The company has received Chemexcil Top Export Award
  • It has also received Chemexcil Trishul Award for Consistent Export Performance
  • It has received the Government of Maharashtra's Export Award
  • Ministry of Commerce's Award from the President of India was conferred on the company.
  • 2010
    • BDH Industries won ‘Good Corporate Citizen’ Award by Bombay Chamber of Commerce & Industry 2010
    • BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
    • WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback